Ma-Home Acute Migraine Lapaʻau Nā hopena

Ua hoʻolaha ʻo CEFALY Technology i kēia lā i nā hopena o kahi noiʻi lapaʻau e hōʻike ana i ka mālama ʻana i ʻelua hola me ka mea e-TNS CEFALY he mea palekana a maikaʻi hoʻi, ʻaʻole lāʻau lapaʻau no ka mālama ʻana i nā hōʻeha o ka migraine ma waho o ka halemai.

ʻO ka hoʻāʻo ʻana o ka e-TNS no ka hoʻomaʻamaʻa ʻana o ka Migraine (TEAM) ʻo ia ka hoʻāʻo mua ʻana o ka hoʻāʻo ʻana o 2-hola e-TNS no ka hoʻouka ʻana o ka migraine ma kahi home. hiʻohiʻona. ʻO ke aʻo ʻana ʻo TEAM ʻo ia ka hoʻāʻo hoʻāʻo hoʻopunipuni nui loa e nānā ana i ka hoʻohana ʻana i kekahi e-TNS therapy no ka mālama ʻana i ka maʻi ʻeha o ka migraine.

ʻO kahi maʻi neurological maʻamau a hoʻonāwaliwali, ua helu ʻia ka migraine e ka Honua

ʻO ka Health Organization ka lua o ke kumu nui o ke kino kīnā o ka honua. Nui nā palena i nā lāʻau anti-migraine maʻamau. Eia kekahi, makemake nui nā poʻe maʻi e pale i nā lāʻau lapaʻau e mālama i ko lākou mau poʻo migraine. ʻO ka hopena, hiki i ka 40% o nā maʻi maʻi migraine i loaʻa ʻole nā ​​​​pono no kēia mālama migraine.

ʻO ka hoʻoulu ʻana o nā aʻalolo trigeminal waho (e-TNS) kahi lāʻau lapaʻau e hāʻawi ana i kahi ala non-pharmacological, non-invasive no nā poʻe maʻi me ka migraine makemake e pale i nā lāʻau lapaʻau, loaʻa i ka intolerances i nā lāʻau lapaʻau a i ʻole, koi i ka lāʻau hoʻohui i kā lākou hoʻokele migraine. Hoʻohana ʻia ma ka lae, hāʻawi ka mea CEFALY e-TNS i kahi hoʻoulu uila maʻalahi e hōʻemi i nā hōʻailona ʻeha o ke aʻalolo trigeminal, kahi ala mua no ka ʻeha migraine.

ʻEiwa mau mahina ka haʻawina TEAM a ua mālama ʻia ma 10 mau kikowaena ma ʻAmelika Hui Pū ʻIa. Ua hoʻopaʻa inoa ʻia ka haʻawina i nā maʻi maʻi 538 mau makahiki 18-65 me ka episodic migraine, me ka aura a i ʻole, ka mea i loaʻa i ka maʻi maʻi maʻamau a i ʻole 2 a 8 mau manawa i kēlā me kēia mahina. ʻO nā kumuhana i hālāwai i nā pae hoʻonaʻauao āpau i hāʻawi ʻia i ka hui verum a i ʻole sham a hāʻawi ʻia i kahi diary headache a aʻo ʻia me ka hoʻohana ʻana i ka mea CEFALY.

I loko o ka manawa 2 mahina, ua aʻo ʻia nā maʻi e hoʻokele ponoʻī i ka mālama ʻana i ka e-TNS, e like me ke aʻo ʻana a me ke aʻo ʻana i loaʻa iā lākou, i loko o 4 mau hola o ka hoʻomaka ʻana o ka migraine a i ʻole i loko o 4 mau hola o ke ala ʻana me ke poʻo o ka migraine. Ua hoʻohana ʻia ʻo Neurostimulation me ka mea CEFALY e-TNS no kahi manawa 2-hola mau.

I ka hui verum, i hoʻohālikelike ʻia me ka hui sham:

• ʻO ke kūʻokoʻa o ka ʻeha ma nā hola 2 he 7.2% kiʻekiʻe (25.5% i hoʻohālikelike ʻia me 18.3%; p = .043)

• ʻO ka hoʻonāʻana o ka hōʻailona pili pili i ka migraine he 14.1% kiʻekiʻe (56.4% i hoʻohālikelikeʻia me 42.3%; p = 0.001)

• ʻO ka hoʻomaha o kaʻeha ma nā hola 2 he 14.3% kiʻekiʻe (69.5% i hoʻohālikelikeʻia me 55.2%; p = 0.001)

• ʻO ka nele o nā hōʻailona pili i ka migraine ma nā hola 2 he 8.4% kiʻekiʻe (42.5% i hoʻohālikelikeʻia me 34.1%; p = 0.044)

• ʻO ke kūʻokoʻa o ka ʻeha a me ka hoʻomaha ʻeha i nā hola 24 he 7.0% a me 11.5% kiʻekiʻe i ka verum (22.8% a me 45.9%) ma mua o sham (15.8 a me 34.4%; p = 0.039)

ʻAʻole i hōʻike ʻia nā hanana koʻikoʻi.

Ua hoʻoholo nā mea kākau noiʻi ʻo ka hoʻohana ʻana i ka lāʻau lapaʻau 2-hola e-TNS i mālama pono ʻia he koho therapeutic palekana a maikaʻi, me ka hoʻohana ʻole ʻana i nā lāʻau anti-migraine acute.

Hāʻawi ka CEFALY i nā mea maʻi i kahi koho lāʻau ʻole no ka pale ʻana a me ka mālama ʻana i ka migraine. He mea kōkua nui ka hoʻohuiʻana i ka lāʻau lapaʻau a hoʻohana paha no nā poʻe i loaʻa kaʻike maikaʻiʻole me nā lāʻau migraine, "wahi a Dr. Deena Kuruvilla, kekahi o nā mea kākau aʻo a me ka Luna Hoʻokele a me ka Board Certified Neuroologist, Westport Headache Institute.

"No laila ka nui o nā poʻe e noho nei me ka ʻeha migraine e makemake nui ana i kahi hopena e hiki ai iā lākou ke hoʻohana me ka palekana ma ka home," wahi a Jen Trainor McDermott, Luna Nui o CEFALY Technology. "E like me ka hōʻike ʻana o ka TEAM iā mākou, hāʻawi ʻo CEFALY i ka hoʻomaha ʻeha ikaika a hoʻomau e pono ai lākou."